Europe Biofilms Treatment Market
The Europe Biofilms Treatment Market size was valued at US$ 454.60 Mn in 2019 and is projected to reach US$ 833.61 Mn by 2027, growing at a CAGR of 7.9% during 2020 - 2027.
Report Coverage
- Product: Debridement Equipment, Gauzes and Dressings, Grafts and Matrices
- Wound: Traumatic and Surgical Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers
- End User: Hospitals, Home Care Settings
US$ 454.60 Mn
Market size in 2019
US$ 833.61 Mn
Market Size by 2027
7.9%
CAGR, 2020 - 2027
2020-2027
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Biofilms Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Biofilms Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Biofilms Treatment Market Regional Analysis
6.2 Europe Biofilms Treatment Market Revenue 2017-2027 (US$ Million)
6.3 Europe Biofilms Treatment Market Forecast Analysis
7. Europe Biofilms Treatment Market Analysis – by Product
7.1 Debridement Equipment
- 7.1.1 Overview
- 7.1.2 Debridement Equipment: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Gauzes and Dressings
- 7.2.1 Overview
- 7.2.2 Gauzes and Dressings: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Grafts and Matrices
- 7.3.1 Overview
- 7.3.2 Grafts and Matrices: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Biofilms Treatment Market Analysis – by Wound
8.1 Traumatic and Surgical Wounds
- 8.1.1 Overview
- 8.1.2 Traumatic and Surgical Wounds: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Diabetic Foot Ulcers
- 8.2.1 Overview
- 8.2.2 Diabetic Foot Ulcers: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Pressure Ulcers
- 8.3.1 Overview
- 8.3.2 Pressure Ulcers: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Venous Leg Ulcers
- 8.4.1 Overview
- 8.4.2 Venous Leg Ulcers: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Biofilms Treatment Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Home Care Settings
- 9.2.1 Overview
- 9.2.2 Home Care Settings: Europe Biofilms Treatment Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Europe Biofilms Treatment Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Biofilms Treatment Market Breakdown, by Key Country, 2020 and 2027 (%)
- 10.2.1.1 Europe Biofilms Treatment Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 UK: Europe Biofilms Treatment Market Breakdown, by Product
- 10.2.1.1.2 UK: Europe Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.1.3 UK: Europe Biofilms Treatment Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Germany: Europe Biofilms Treatment Market Breakdown, by Product
- 10.2.1.2.2 Germany: Europe Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.2.3 Germany: Europe Biofilms Treatment Market Breakdown, by End User
- 10.2.1.3 France: Europe Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 France: Europe Biofilms Treatment Market Breakdown, by Product
- 10.2.1.3.2 France: Europe Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.3.3 France: Europe Biofilms Treatment Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Russia: Europe Biofilms Treatment Market Breakdown, by Product
- 10.2.1.4.2 Russia: Europe Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.4.3 Russia: Europe Biofilms Treatment Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Italy: Europe Biofilms Treatment Market Breakdown, by Product
- 10.2.1.5.2 Italy: Europe Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.5.3 Italy: Europe Biofilms Treatment Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Biofilms Treatment Market Breakdown, by Product
- 10.2.1.6.2 Rest of Europe: Europe Biofilms Treatment Market Breakdown, by Wound
- 10.2.1.6.3 Rest of Europe: Europe Biofilms Treatment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 MiMedx
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ConvaTec Group Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Coloplast Group
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Mölnlycke Health Care AB.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Organogenesis Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Integra Life Sciences Corporation
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 B. Braun Melsungen AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Hartman Group
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Medline Industries, Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Smith & Nephew
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
